1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Needle-Free Drug Delivery Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Jet-based
1.2.3 Spring-based
1.2.4 Laser-based
1.3 Market by Application
1.3.1 Global Needle-Free Drug Delivery Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Insulin delivery
1.3.3 Vaccination
1.3.4 Pain management
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Needle-Free Drug Delivery Market Perspective (2017-2028)
2.2 Needle-Free Drug Delivery Growth Trends by Region
2.2.1 Needle-Free Drug Delivery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Needle-Free Drug Delivery Historic Market Size by Region (2017-2022)
2.2.3 Needle-Free Drug Delivery Forecasted Market Size by Region (2023-2028)
2.3 Needle-Free Drug Delivery Market Dynamics
2.3.1 Needle-Free Drug Delivery Industry Trends
2.3.2 Needle-Free Drug Delivery Market Drivers
2.3.3 Needle-Free Drug Delivery Market Challenges
2.3.4 Needle-Free Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Needle-Free Drug Delivery Players by Revenue
3.1.1 Global Top Needle-Free Drug Delivery Players by Revenue (2017-2022)
3.1.2 Global Needle-Free Drug Delivery Revenue Market Share by Players (2017-2022)
3.2 Global Needle-Free Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Needle-Free Drug Delivery Revenue
3.4 Global Needle-Free Drug Delivery Market Concentration Ratio
3.4.1 Global Needle-Free Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Needle-Free Drug Delivery Revenue in 2021
3.5 Needle-Free Drug Delivery Key Players Head office and Area Served
3.6 Key Players Needle-Free Drug Delivery Product Solution and Service
3.7 Date of Enter into Needle-Free Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Needle-Free Drug Delivery Breakdown Data by Type
4.1 Global Needle-Free Drug Delivery Historic Market Size by Type (2017-2022)
4.2 Global Needle-Free Drug Delivery Forecasted Market Size by Type (2023-2028)
5 Needle-Free Drug Delivery Breakdown Data by Application
5.1 Global Needle-Free Drug Delivery Historic Market Size by Application (2017-2022)
5.2 Global Needle-Free Drug Delivery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Needle-Free Drug Delivery Market Size (2017-2028)
6.2 North America Needle-Free Drug Delivery Market Size by Country (2017-2022)
6.3 North America Needle-Free Drug Delivery Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Needle-Free Drug Delivery Market Size (2017-2028)
7.2 Europe Needle-Free Drug Delivery Market Size by Country (2017-2022)
7.3 Europe Needle-Free Drug Delivery Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Needle-Free Drug Delivery Market Size (2017-2028)
8.2 Asia-Pacific Needle-Free Drug Delivery Market Size by Country (2017-2022)
8.3 Asia-Pacific Needle-Free Drug Delivery Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Needle-Free Drug Delivery Market Size (2017-2028)
9.2 Latin America Needle-Free Drug Delivery Market Size by Country (2017-2022)
9.3 Latin America Needle-Free Drug Delivery Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Needle-Free Drug Delivery Market Size (2017-2028)
10.2 Middle East & Africa Needle-Free Drug Delivery Market Size by Country (2017-2022)
10.3 Middle East & Africa Needle-Free Drug Delivery Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Antares Pharma
11.1.1 Antares Pharma Company Detail
11.1.2 Antares Pharma Business Overview
11.1.3 Antares Pharma Needle-Free Drug Delivery Introduction
11.1.4 Antares Pharma Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.1.5 Antares Pharma Recent Development
11.2 Pharmajet
11.2.1 Pharmajet Company Detail
11.2.2 Pharmajet Business Overview
11.2.3 Pharmajet Needle-Free Drug Delivery Introduction
11.2.4 Pharmajet Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.2.5 Pharmajet Recent Development
11.3 Optinose
11.3.1 Optinose Company Detail
11.3.2 Optinose Business Overview
11.3.3 Optinose Needle-Free Drug Delivery Introduction
11.3.4 Optinose Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.3.5 Optinose Recent Development
11.4 Valeritas
11.4.1 Valeritas Company Detail
11.4.2 Valeritas Business Overview
11.4.3 Valeritas Needle-Free Drug Delivery Introduction
11.4.4 Valeritas Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.4.5 Valeritas Recent Development
11.5 Crossject
11.5.1 Crossject Company Detail
11.5.2 Crossject Business Overview
11.5.3 Crossject Needle-Free Drug Delivery Introduction
11.5.4 Crossject Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.5.5 Crossject Recent Development
11.6 Injex Pharma
11.6.1 Injex Pharma Company Detail
11.6.2 Injex Pharma Business Overview
11.6.3 Injex Pharma Needle-Free Drug Delivery Introduction
11.6.4 Injex Pharma Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.6.5 Injex Pharma Recent Development
11.7 3M Pharmaceuticals
11.7.1 3M Pharmaceuticals Company Detail
11.7.2 3M Pharmaceuticals Business Overview
11.7.3 3M Pharmaceuticals Needle-Free Drug Delivery Introduction
11.7.4 3M Pharmaceuticals Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.7.5 3M Pharmaceuticals Recent Development
11.8 Becton Dickinson (BD)
11.8.1 Becton Dickinson (BD) Company Detail
11.8.2 Becton Dickinson (BD) Business Overview
11.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Introduction
11.8.4 Becton Dickinson (BD) Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.8.5 Becton Dickinson (BD) Recent Development
11.9 MedImmune
11.9.1 MedImmune Company Detail
11.9.2 MedImmune Business Overview
11.9.3 MedImmune Needle-Free Drug Delivery Introduction
11.9.4 MedImmune Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.9.5 MedImmune Recent Development
11.10 Mystic Pharmaceuticals
11.10.1 Mystic Pharmaceuticals Company Detail
11.10.2 Mystic Pharmaceuticals Business Overview
11.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Introduction
11.10.4 Mystic Pharmaceuticals Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.10.5 Mystic Pharmaceuticals Recent Development
11.11 Zogenix
11.11.1 Zogenix Company Detail
11.11.2 Zogenix Business Overview
11.11.3 Zogenix Needle-Free Drug Delivery Introduction
11.11.4 Zogenix Revenue in Needle-Free Drug Delivery Business (2017-2022)
11.11.5 Zogenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
